Aignostics combines proprietary access to multimodal clinical datasets, industry-leading AI technologies, and rigorous science to develop best-in-class insights for the next generation of precision medicine. Through collaborations with its biopharma partners, Aignostics supports drug discovery, translational research, clinical trials, and CDx development across multiple therapeutic areas. Established in 2018, Aignostics is a spin-off from Charité Berlin, one of the world’s largest and most esteemed university hospitals. Aignostics is funded by leading VC investors and has operations in Berlin and New York.
| Website | http://www.aignostics.com |
| Revenue | $21 million |
| Employees | 138 (108 on RocketReach) |
| Founded | 2018 |
| Address | Alt-Moabit 73, Berlin, Berlin 10555, DE |
| Technologies |
JavaScript
,
HTML
,
PHP
+15 more
(view full list)
|
| Industry | Software Development, Artificial Intelligence, Decision/Risk Analysis, Data and Analytics, Diagnostic Equipment, Science and Engineering, Software, Health Care, Machine Learning |
| Keywords | Precision Medicine, Ai Driven Diagnostics, Medical Data Science, Advanced Diagnostics, Machine Learning Healthcare, Next Generation Diagnostics, Biomarker Discovery, Artificial Intelligence Medicine, Clinical Decision Support, Healthcare Analytics, Data Driven Healthcare, Digital Health, Health Informatics, Big Data Analytics, Scientific Research, Drug Discovery, Therapeutic Target Identification |
| Competitors | Tempus Labs, Inc., Biofourmis, Freenome, GRAIL, PathAI, Proscia, SignalPath, Zebra Medical Vision Ltd, Aiforia Technologies, CureMetrix +37 more (view full list) |
Looking for a particular Aignostics employee's phone or email?
The Aignostics annual revenue was $21 million in 2026.
Viktor Matyas is the Co-founder and CEO of Aignostics.
108 people are employed at Aignostics.
Aignostics is based in Berlin, Berlin.